Institutional investors purchased a net $862.9 thousand shares of KERX during the quarter ended March 2017 and now own 64.02% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CUTLER GROUP LP Bought 736.00 shares of Keryx Biopharmaceuticals ...
APERIO GROUP LLC Bought 472.00 shares of Keryx Biopharmaceuticals ...